Canadian Online Pharmacy

CDER New April 25, 2013

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

April 24, 2013

April 23, 2013


New and Generic Drug Approvals

April 23, 2013

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Fluvoxamine Maleate fluvoxamine maleate Capsule, Extended Release; Oral Actavis Elizabeth Approval
Fluvoxamine Maleate fluvoxamine maleate Capsule, Extended Release; Oral Actavis Elizabeth Tentative Approval
Guanfacine Hydrochloride guanfacine hydrochloride Tablet, Extended Release; Oral Teva Pharms Usa Tentative Approval
Olux E clobetasol propionate Aerosol, Foam; Topical Stiefel Labs Inc Labeling Revision
Simponi golimumab Injectable; Injection Centocor Ortho Biotech Inc Labeling Revision
Sumatriptan Succinate sumatriptan succinate Injectable; Subcutaneous Aurobindo Pharma Ltd Approval
Telmisartan telmisartan Tablet; Oral Alembic Ltd Tentative Approval

 

April 22, 2013

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Actiq fentanyl citrate Troche/Lozenge; Transmucosal Cephalon Manufacturing Change or Addition
Cardiogen-82 rubidium chloride rb-82 Injectable; Injection Bracco Manufacturing Change or Addition
Cogentin benztropine mesylate Injectable; Injection Oak Pharms Akorn Labeling Revision
Welchol colesevelam hydrochloride Tablet; Oral Daiichi Sankyo Manufacturing Change or Addition

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery